Rhythm Pharmaceuticals (RYTM) Inventory Average (2023 - 2026)
Rhythm Pharmaceuticals (RYTM) posted quarterly Inventory Average of $27.2 million for Q1 2026, up 42.95% year-over-year from $19.0 million in Q1 2025, and up 13.67% quarter-over-quarter from $23.9 million in Q4 2025.
Rhythm Pharmaceuticals (RYTM) Inventory Average (2023 - 2026) Analysis & Trends
Rhythm Pharmaceuticals (RYTM) has reported Inventory Average for 4 consecutive years, with $27.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Inventory Average rose 42.95% year-over-year to $27.2 million; the TTM figure through Mar 2026 stood at $27.2 million (up 42.95% YoY), while the FY2025 annual figure was $22.2 million, up 62.59% from the prior year.
- Inventory Average advanced to $27.2 million in Q1 2026 per RYTM's latest filing, from $23.9 million in the prior quarter.
- Across five years, Inventory Average topped out at $27.2 million in Q1 2026 and bottomed at $4.2 million in Q1 2023.
- Historically, Inventory Average has averaged $14.1 million across 4 years, with a median of $12.9 million in 2024.
- Annual changes were most pronounced in 2025 — Inventory Average soared 122.15% — and 2026, when it soared 42.95%.
- Rhythm Pharmaceuticals' Inventory Average stood at $8.2 million in 2023, then jumped by 99.17% to $16.3 million in 2024, then soared by 46.65% to $23.9 million in 2025, then grew by 13.67% to $27.2 million in 2026.
- Business Quant data shows RYTM's Inventory Average at $27.2 million in Q1 2026, $23.9 million in Q4 2025, and $20.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 707.10 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 355,998.06 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 90.57 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 137.65 Mn |
| 10 | Rhythm Pharmaceuticals | 7.95 Bn | 7.62 Bn | 62.32 Mn | 29.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 29.58 Mn |
| Mar 31, 2026 | 27.20 Mn |
| Dec 31, 2025 | 23.93 Mn |
| Sep 30, 2025 | 20.49 Mn |
| Jun 30, 2025 | 19.09 Mn |
| Mar 31, 2025 | 19.03 Mn |
| Dec 31, 2024 | 16.32 Mn |
| Sep 30, 2024 | 12.94 Mn |
| Jun 30, 2024 | 10.25 Mn |
| Mar 31, 2024 | 8.57 Mn |
| Dec 31, 2023 | 8.19 Mn |
| Sep 30, 2023 | 6.97 Mn |
| Jun 30, 2023 | 5.83 Mn |
| Mar 31, 2023 | 4.20 Mn |